The Current and Future Landscape of SERCA Gene Therapy for Heart Failure: A Clinical Perspective

被引：30

作者：

Hayward, Carl ^{[1
]}

Banner, Nicholas R. ^{[2
]}

Morley-Smith, Andrew ^{[1
]}

Lyon, Alexander R. ^{[1
]}

Harding, Sian E. ^{[3
]}

机构：

[1] Royal Brompton Hosp, Cardiovasc Biomed Res Unit, London SW3 6NP, England

[2] Royal Brompton & Harefield NHS Trust, Harefield Hosp, Harefield UB9 6JH, Middx, England

[3] Univ London Imperial Coll Sci Technol & Med, London SW3 6NP, England

来源：

HUMAN GENE THERAPY | 2015年 / 26卷 / 05期

关键词：

SARCOPLASMIC-RETICULUM CA2+-ATPASE; SMOOTH-MUSCLE-CELLS; CALCIUM UP-REGULATION; NEUTRALIZING ANTIBODIES; DILATED CARDIOMYOPATHY; CARDIAC-FUNCTION; VENTRICULAR-ARRHYTHMIAS; MYOCARDIAL-INFARCTION; FAILING HUMAN; RAT MYOCYTES;

D O I：

10.1089/hum.2015.018

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Gene therapy has been applied to cardiovascular disease for over 20 years but it is the application to heart failure that has generated recent interest in clinical trials. There is laboratory and early clinical evidence that delivery of sarcoplasmic reticulum calcium ATPase 2a (SERCA2a) gene therapy is beneficial for heart failure and this therapy could become the first positive inotrope with anti-arrhythmic properties. In this review we will discuss the rationale for SERCA2a gene therapy as a viable strategy in heart failure, review the published data, and discuss the ongoing clinical trials, before concluding with comments on the future challenges and potential for this therapy.

引用

页码：293 / 304

页数：12

共 50 条

[21] SERCA2a Gene Therapy Can Improve Symptomatic Heart Failure in δ-Sarcoglycan-Deficient Animals
Bouyon, Sophie
Roussel, Veronique
Fromes, Yves
HUMAN GENE THERAPY, 2014, 25 (08) : 694 - 704
[22] Heart failure research in China: current status and future direction
Zhu, Yuangui
Sun, Ruijuan
Dong, Erdan
SCIENCE BULLETIN, 2016, 61 (23) : 1793 - 1801
[23] Advances in Gene Therapy for Heart Failure
Fish, Kenneth M.
Ishikawa, Kiyotake
DISCOVERY MEDICINE, 2015, 19 (105) : 285 - 291
[24] Emerging Strategies for Chronic Heart Failure: The Role of Gene Therapy
Milano, Elena Giulia
Cicoira, Mariantonietta
REVIEWS IN CARDIOVASCULAR MEDICINE, 2012, 13 (04) : E161 - E168
[25] Current Approaches to Antiarrhythmic Therapy in Heart Failure
Rose-Jones, Lisa J.
Bode, Weeranun D.
Gehi, Anil K.
HEART FAILURE CLINICS, 2014, 10 (04) : 635 - +
[26] Pediatric Heart Failure: Current State and Future Possibilities
Rossano, Joseph W.
Jang, Gi Young
KOREAN CIRCULATION JOURNAL, 2015, 45 (01) : 1 - 8
[27] Current and future G protein-coupled receptor signaling targets for heart failure therapy
Siryk-Bathgate, Ashley
Dabul, Samalia
Lymperopoulos, Anastasios
DRUG DESIGN DEVELOPMENT AND THERAPY, 2013, 7 : 1209 - 1222
[28] Current and future prospects for hemophilia gene therapy
Ward, Peter
Walsh, Christopher E.
EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (07) : 649 - 659
[29] Gene therapy for heart failure: A novel treatment for the age old disease
Vora, Neel
Patel, Parth
Gajjar, Aarsh
Ladani, Parva
Konat, Ashwati
Bhanderi, Devanshi
Gadam, Srikanth
Prajjwal, Priyadarshi
Sharma, Kamal
Arunachalam, Shivaram Poigai
DM DISEASE-A-MONTH, 2024, 70 (02):
[30] Prospects for gene transfer for clinical heart failure
Tang, T.
Gao, M. H.
Hammond, H. Kirk
GENE THERAPY, 2012, 19 (06) : 606 - 612

← 1 2 3 4 5 →